4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

8.60

-0.09 (-1.04%)

At close: May 22, 2026, 4:00 PM EDT

8.57

-0.03 (-0.35%)

After-hours: May 22, 2026, 6:14 PM EDT

4D Molecular Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	72.49	60.24	149.34	249.11	52.35	153
Short-Term Investments	318.4	342.41	275.54	39.12	161.2	94.78
Cash & Short-Term Investments	390.89	402.66	424.88	288.23	213.55	247.78
Cash Growth	21.61%	-5.23%	47.41%	34.97%	-13.81%	-10.46%
Accounts Receivable	-	-	-	-	-	0.05
Other Current Assets	14.47	10.48	10.06	8.36	6.96	8.46
Total Current Assets	405.36	413.13	434.93	296.59	220.51	256.28
Net Property, Plant & Equipment	30.94	33.01	40.61	31.67	35.35	28.95
Long-Term Investments	66.74	111.38	80.58	10.95	4.91	67.65
Other Long-Term Assets	9.86	9.19	4.26	0.68	1.08	0.6
Total Assets	512.91	566.71	560.38	339.89	261.85	353.49
Accounts Payable	14.69	11.16	4.39	3.52	3.32	4.76
Accrued Expenses	22.87	26.87	18.87	12.01	8.87	7.74
Current Portion of Leases	5.49	5.59	5.64	3.15	2.66	1.23
Unearned Revenue	0.36	0.36	0.26	0.27	0.88	2.6
Total Current Liabilities	43.4	43.99	29.15	18.95	15.73	16.34
Long-Term Leases	15.05	15.82	18.97	11.52	13.47	15.22
Other Long-Term Liabilities	2.62	1.24	1.66	1.59	1.31	2.83
Total Long-Term Liabilities	17.67	17.06	20.63	13.11	14.78	18.04
Total Liabilities	61.07	61.05	49.78	32.06	30.51	34.38
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-in Capital	1,237	1,221	1,087	723.14	547.02	526.52
Accumulated Other Comprehensive Income	-0.18	0.73	0.23	0.02	-1.2	-0.42
Retained Earnings	-785.06	-716.3	-576.2	-415.33	-314.49	-207
Shareholders' Equity	451.84	505.66	510.61	307.83	231.34	319.11
Total Liabilities & Equity	512.91	566.71	560.38	339.89	261.85	353.49
Total Debt	20.54	21.41	24.61	14.67	16.12	16.45
Net Cash (Debt)	370.36	381.24	400.27	273.56	197.43	231.33
Net Cash Growth	-2.85%	-4.75%	46.32%	38.56%	-14.65%	-16.41%
Net Cash Per Share	6.07	6.58	7.42	6.99	6.10	8.34
Book Value	451.84	505.66	510.61	307.83	231.34	319.11
Book Value Per Share	7.41	8.73	9.47	7.87	7.15	11.51
Tangible Book Value	451.84	505.66	510.61	307.83	231.34	319.11
Tangible Book Value Per Share	7.41	8.73	9.47	7.87	7.15	11.51

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q